News

LTTS launches AI tool that creates 3D lung models to help doctors plan surgeriesLTTS has launched an AI-powered platform that turns CT scans into 3D lung models, helping doctors better plan surgeries, navigate procedures and improve respiratory diagnostics.By Bhupendra Paintola  March 16, 2026, 5:48:36 PM IST (Published)3 Min ReadL&T Technology Services (LTTS) has launched a next-generation, AI-powered digital twin platform designed to assist clinicians with lung navigation, surgical planning and respiratory diagnostics, as the healthcare industry increasingly turns to simulation-driven tools to improve precision medicine.

The platform combines LTTS’ expertise in medical imaging, AI-driven diagnostics and connected healthcare systems with AI infrastructure from NVIDIA to enable visualisation of lung anatomy and support better clinical outcomes.

LTTS’ lung digital twin solution integrates directly with CT imaging workflows and uses deep learning models to reconstruct a comprehensive 3D digital twin of the lungs.

The system allows clinicians to visualise critical anatomical structures such as airways, blood vessels, lung lobes and lesions, and explore patient-specific anatomy in an immersive digital environment while simulating procedural pathways for bronchoscopy and biopsy planning.

The platform is powered by NVIDIA’s Physical AI infrastructure, including Omniverse and OpenUSD for interactive 3D visualization of lung anatomy, TensorRT for optimised AI inference across clinical workflows, and MONAI to enable advanced medical image segmentation and automated identification of airways, vessels, tumors and lung lobes.

By transforming static CT scans into simulation-ready digital models, the platform allows clinicians to analyse anatomical relationships, plan surgical pathways and navigate bronchoscopic procedures with greater accuracy. It also supports automated segmentation, volumetric analysis and navigation path planning, which can help reduce pre-operative planning time and improve procedural safety.

“By combining LTTS’ engineering expertise in medical imaging and digital health platforms with the power of NVIDIA’s Physical AI infrastructure, we are enabling a new generation of AI-powered biological digital twins for precision medicine,” said L&T Technology Services'  CEO & MD Amit Chadha.

Echoing the potential of digital twin technologies in healthcare, David Niewolny said, “Digital twins are emerging as a powerful new tool for precision medicine. By leveraging NVIDIA Physical AI infrastructure, Omniverse, MONAI and TensorRT, LTTS is transforming CT data into interactive lung digital twins that allow clinicians to visualise anatomy in 3D, simulate procedures and plan clinical interventions with greater confidence.”

LTTS, a subsidiary of Larsen & Toubro (L&T), is an engineering research and development (ER&D) services company that offers design, development, testing, and digital engineering solutions across sectors like transportation (automotive, aerospace), industrial products, telecom/hi-tech, medical devices, plant engineering, semiconductors and AI/IoT.

Also read: LTTS cuts FY26 growth guidance; Q3 profit slips sequentially, margins improve

The development comes at a time when respiratory diseases such as lung cancer and chronic obstructive pulmonary disease (COPD) continue to rise globally. AI-driven digital twin technologies are increasingly expected to shift healthcare from traditional imaging interpretation to predictive, simulation-driven treatment planning, enabling more personalised and minimally invasive interventions.

Shares of LTTS ended today's trade 3.8% lower at 3,299 on the NSE. On a year-to-date basis, the shares have given a negative return of 24.6%.Continue ReadingTagsAI in healthcareLTTSNvidia